| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1096 | 2016 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1045 | 2019 |
| Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals F Conti, F Buonfiglioli, A Scuteri, C Crespi, L Bolondi, P Caraceni, ... Journal of hepatology 65 (4), 727-733, 2016 | 1016 | 2016 |
| Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status F Trevisani, PE D'Intino, AM Morselli-Labate, G Mazzella, E Accogli, ... Journal of hepatology 34 (4), 570-575, 2001 | 876 | 2001 |
| Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: a retrospective study S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ... Hepatology 45 (3), 579-587, 2007 | 759 | 2007 |
| Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis A Colecchia, L Montrone, E Scaioli, ML Bacchi–Reggiani, A Colli, ... Gastroenterology 143 (3), 646-654, 2012 | 575 | 2012 |
| Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis G Mazzella, E Accogli, S Sottili, D Festi, M Orsini, A Salzetta, V Novelli, ... Journal of hepatology 24 (2), 141-147, 1996 | 360 | 1996 |
| Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project) D Festi, A Dormi, S Capodicasa, T Staniscia, AF Attili, P Loria, P Pazzi, ... World journal of gastroenterology: WJG 14 (34), 5282, 2008 | 287 | 2008 |
| The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment‐naïve hepatitis C patients R Flisiak, SV Feinman, M Jablkowski, A Horban, W Kryczka, ... Hepatology 49 (5), 1460-1468, 2009 | 281 | 2009 |
| Gallstone recurrence after successful oral bile acid treatment: a 12-year follow-up study and evaluation of long-term postdissolution treatment N Villanova, F Bazzoli, F Taroni, R Frabboni, G Mazzella, D Festi, ... Gastroenterology 97 (3), 726-731, 1989 | 238 | 1989 |
| Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers G Mazzella, R Nicola, A Francesco, S Patrizia, B Luciano, M Anna, ... Hepatology 33 (3), 504-508, 2001 | 233 | 2001 |
| Enzymatic determination of cholesterol in bile A Roda, D Festi, C Sama, G Mazzella, R Aldini, E Roda, L Barbara Clinica Chimica Acta 64 (3), 337-341, 1975 | 172 | 1975 |
| Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study A Colecchia, A Colli, G Casazza, D Mandolesi, R Schiumerini, ... Journal of Hepatology 60 (6), 1158-1164, 2014 | 163 | 2014 |
| Ursodeoxycholic Acid Vs. Chenodeoxycholic Acid As Cholesterol Gallstone–Dissolving Agents: A Comparative Randomized Study E Roda, F Bazzoli, AMM Labate, G Mazzella, A Roda, C Sama, D Festi, ... Hepatology 2 (6), 804-810, 1982 | 162 | 1982 |
| Gallbladder motility in cholesterol gallstone disease: effect of ursodeoxycholic acid administration and gallstone dissolution D Festi, R Frabboni, F Bazzoli, A Sangermano, M Ronchi, L Rossi, ... Gastroenterology 99 (6), 1779-1785, 1990 | 149 | 1990 |
| Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) D Festi, S Sottili, A Colecchia, A Attili, G Mazzella, E Roda, F Romano, ... Hepatology 30 (4), 839-846, 1999 | 142 | 1999 |
| Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease A Colecchia, A Vestito, F Pasqui, G Mazzella, E Roda, F Pistoia, ... World journal of gastroenterology: WJG 13 (2), 264, 2007 | 134 | 2007 |
| Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects S Spinozzi, C Colliva, C Camborata, M Roberti, C Ianni, F Neri, ... Journal of Natural Products 77 (4), 766-772, 2014 | 132 | 2014 |
| Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis A Lisotti, F Azzaroli, F Buonfiglioli, M Montagnani, P Cecinato, L Turco, ... Hepatology 59 (2), 643-650, 2014 | 130 | 2014 |
| Adverse effects of proton pump inhibitors F Lodato, F Azzaroli, L Turco, N Mazzella, F Buonfiglioli, M Zoli, ... Best practice & research Clinical gastroenterology 24 (2), 193-201, 2010 | 128 | 2010 |
